Literature DB >> 31214860

Ironing out pyoverdine's chromophore structure: serendipity or design?

Christine Cézard1, Benjamin Bouvier2, Pascal Sonnet3.   

Abstract

Pyoverdines are Pseudomonas aeruginosa's primary siderophores. These molecules, composed of a fluorescent chromophore attached to a peptide chain of 6-14 amino acids, are synthesized by the bacterium to scavenge iron (essential to its survival and growth) from its environment. Hijacking the siderophore pathway to use pyoverdine-antibiotic compounds in a Trojan horse approach has shown promise but remains very challenging because of the synthetic efforts involved. Indeed, both possible approaches (grafting an antibiotic on pyoverdine harvested from Pseudomonas or designing a total synthesis route) are costly, time-consuming and low-yield tasks. Designing comparatively simple analogs featuring the salient properties of the original siderophore is thus crucial for the conception of novel antibiotics to fight bacterial resistance. In this work, we focus on the replacement of the pyoverdine chromophore, a major roadblock on the synthetic pathway. We propose three simpler analogs and evaluate their ability to complex iron and interact with the FpvA transporter using molecular modeling techniques. Based on these results, we discuss the role of the native chromophore's main features (polycyclicity, positive charge, flexibility) on pyoverdine's ability to bind iron and be recognized by membrane transporter FpvA and propose guidelines for the design of effective synthetic siderophores.

Entities:  

Keywords:  Antibiotics; Chemical biology; Drug design; In silico; Pseudomonas aeruginosa; Siderophore

Mesh:

Substances:

Year:  2019        PMID: 31214860     DOI: 10.1007/s00775-019-01678-x

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  49 in total

Review 1.  Alternatives to antibiotics-a pipeline portfolio review.

Authors:  Lloyd Czaplewski; Richard Bax; Martha Clokie; Mike Dawson; Heather Fairhead; Vincent A Fischetti; Simon Foster; Brendan F Gilmore; Robert E W Hancock; David Harper; Ian R Henderson; Kai Hilpert; Brian V Jones; Aras Kadioglu; David Knowles; Sigríður Ólafsdóttir; David Payne; Steve Projan; Sunil Shaunak; Jared Silverman; Christopher M Thomas; Trevor J Trust; Peter Warn; John H Rex
Journal:  Lancet Infect Dis       Date:  2016-01-13       Impact factor: 25.071

2.  Prevalence of multidrug-resistant Pseudomonas aeruginosa and carbapenem-resistant Enterobacteriaceae among specimens from hospitalized patients with pneumonia and bloodstream infections in the United States from 2000 to 2009.

Authors:  Marya D Zilberberg; Andrew F Shorr
Journal:  J Hosp Med       Date:  2013-09-10       Impact factor: 2.960

3.  Switching between apparently redundant iron-uptake mechanisms benefits bacteria in changeable environments.

Authors:  Zoé Dumas; Adin Ross-Gillespie; Rolf Kümmerli
Journal:  Proc Biol Sci       Date:  2013-06-12       Impact factor: 5.349

Review 4.  Bacterial biofilm development as a multicellular adaptation: antibiotic resistance and new therapeutic strategies.

Authors:  César de la Fuente-Núñez; Fany Reffuveille; Lucía Fernández; Robert E W Hancock
Journal:  Curr Opin Microbiol       Date:  2013-07-20       Impact factor: 7.934

5.  Permeability Barrier of Gram-Negative Cell Envelopes and Approaches To Bypass It.

Authors:  Helen I Zgurskaya; Cesar A Löpez; S Gnanakaran
Journal:  ACS Infect Dis       Date:  2015       Impact factor: 5.084

6.  [Speech disorders in traumatically caused occlusion of both vertebral arteries].

Authors:  J Wendler; M Schädlich
Journal:  Folia Phoniatr (Basel)       Date:  1966

7.  Thirteen years of antibiotic susceptibility surveillance of Pseudomonas aeruginosa from intensive care units and urology services in the Netherlands.

Authors:  P D Croughs; B Li; J A A Hoogkamp-Korstanje; E Stobberingh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-09-08       Impact factor: 3.267

Review 8.  Linezolid (ZYVOX), the first member of a completely new class of antibacterial agents for treatment of serious gram-positive infections.

Authors:  Steven J Brickner; Michael R Barbachyn; Douglas K Hutchinson; Peter R Manninen
Journal:  J Med Chem       Date:  2008-03-14       Impact factor: 7.446

9.  Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: active efflux as a contributing factor to beta-lactam resistance.

Authors:  X Z Li; D Ma; D M Livermore; H Nikaido
Journal:  Antimicrob Agents Chemother       Date:  1994-08       Impact factor: 5.191

10.  Broad-spectrum anti-biofilm peptide that targets a cellular stress response.

Authors:  César de la Fuente-Núñez; Fany Reffuveille; Evan F Haney; Suzana K Straus; Robert E W Hancock
Journal:  PLoS Pathog       Date:  2014-05-22       Impact factor: 6.823

View more
  1 in total

1.  Design of Polymeric Thin Films to Direct Microbial Biofilm Growth, Virulence, and Metabolism.

Authors:  Trevor Franklin; Yinan Wu; Jiayan Lang; Sijin Li; Rong Yang
Journal:  Biomacromolecules       Date:  2021-10-25       Impact factor: 6.978

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.